Skip Navigation


NDT Advance Access originally published online on August 16, 2005
Nephrology Dialysis Transplantation 2005 20(11):2402-2407; doi:10.1093/ndt/gfi074
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/11/2402    most recent
gfi074v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Incerti, J.
Right arrow Articles by de Azevedo, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Incerti, J.
Right arrow Articles by de Azevedo, M. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org


Original Article

Evaluation of tests for microalbuminuria screening in patients with diabetes

Juliane Incerti1, Themis Zelmanovitz1, Joiza Lins Camargo2, Jorge Luiz Gross1 and Mirela Jobim de Azevedo1

1 Endocrine Division and 2 Clinical Pathology Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil

Correspondence and offprint requests to: Mirela Jobim de Azevedo, MD, Serviço de Endocrinologia, Hospital de Clinicas de Porto Alegre, Rua Ramiro Barcelos 2350/Predio 12/4° andar, 90035-003, Porto Alegre, RS, Brazil. Email: mirelaazevedo{at}terra.com.br

Background. The first step in the diagnosis of diabetic nephropathy is to measure albumin in a spot urine sample. The aim of this study was to assess the accuracy of urinary albumin concentration (UAC), urinary albumin-to-creatinine ratio (UACR), and the Micral-Test II in a random urine specimen (RUS) for microalbuminuria screening in diabetes mellitus.

Methods. Two hundred and seventy-eight patients collected 24 h timed urine specimens followed by RUS. Albumin (immunoturbidimetry) and creatinine were measured in protein-negative (Combur-Test) urine samples. Samples were classified as normoalbuminuric [24 h urinary albumin excretion rate (UAER) <20 µg/min; n = 189] and microalbuminuric (UAER =20–199 µg/min; n = 89). Micral-Test II readings were performed in 130 RUS. Receiver operating characteristics (ROC) curves were constructed using UAER as the reference standard.

Results. The areas under the ROC curves were similar for UAC (0.934±0.032) and UACR (0.920±0.035; P = 0.626), but the Micral-Test II had lower accuracy to diagnose microalbuminuria (area = 0.846±0.047) than UAC (P = 0.014). The first cutoff point with 100% sensitivity for UAC was 14.4 mg/l (specificity =77.2%), and 15.7 mg/g for UACR (specificity =73.0%). Concerning the Micral-Test II, sensitivity and specificity for the 20 mg/l cutoff point were 90.0 and 46.0%, respectively. The agreement between UAER and the Micral-Test II for microalbuminuria diagnosis was 55.8% ({kappa} = 0.22; P<0.001). The cost of diagnosing microalbuminuria was U$1.74 (UAC), U$2.00 (UACR) and U$4.09 (Micral-Test II) per patient.

Conclusions. Measurement of UAC in a RUS was the best choice for the diagnosis screening of microalbuminuria in diabetic patients, considering cost and accuracy.

Keywords: diabetes mellitus; diabetic nephropathy; Micral-Test II; microalbuminuria; screening tests; urinary albumin excretion rate


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann Clin BiochemHome page
E. J Lamb, F. MacKenzie, and P. E Stevens
How should proteinuria be detected and measured?
Ann Clin Biochem, May 1, 2009; 46(3): 205 - 217.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. K. Kramer, J. Camargo, E. D. Ricardo, F. K. Almeida, L. H. Canani, J. L. Gross, and M. J. Azevedo
Does bacteriuria interfere with albuminuria measurements of patients with diabetes?
Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1193 - 1196.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. C. Witte, H. J. Lambers Heerspink, D. de Zeeuw, S. J.L. Bakker, P. E. de Jong, and R. Gansevoort
First Morning Voids Are More Reliable Than Spot Urine Samples to Assess Microalbuminuria
J. Am. Soc. Nephrol., February 1, 2009; 20(2): 436 - 443.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. L. Camargo, G. M. Lara, A. E. Wendland, J. L. Gross, and M. J. de Azevedo
Agreement of Different Immunoassays for Urinary Albumin Measurement
Clin. Chem., May 1, 2008; 54(5): 925 - 927.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.